BCWORLD PHARM. Co., Ltd.
KOSDAQ 200780.KQ
BCWORLD PHARM. Co., Ltd. Price to Book Ratio (P/B) on January 14, 2025: 0.48
-
BCWORLD PHARM. Co., Ltd. 52-week high Price to Book Ratio (P/B) is 0.71 on March 12, 2024, which is 48.09% above the current Price to Book Ratio (P/B).
-
BCWORLD PHARM. Co., Ltd. 52-week low Price to Book Ratio (P/B) is 0.37 on December 09, 2024, which is -23.33% below the current Price to Book Ratio (P/B).
-
BCWORLD PHARM. Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 0.55.
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
| CEO | Mr. Sung-Han Hong |
| IPO Date | Dec. 15, 2014 |
| Location | South Korea |
| Headquarters | 22 Geumto-ro 40beon-gil |
| Employees | 284 |
| Sector | Health Care |
| Industries | |
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.
Past 5 years
USD 64.45
USD 38.12
USD 17.02
USD 171.86
StockViz Staff
January 15, 2025
Any question? Send us an email